Guillain-Barre syndrome related to COVID-19 infection

At the time of this writing, healthcare systems are facing worldwide the pandemic of the coronavirus severe acute respiratory coronavirus 2 (SARS-COV-2) and its associated disease, named cronavirus disease 19 (COVID-19). This virus is a new human pathogen, and currently, there are no specific treatment options.1 COVID-19 mostly affects the respiratory system, ranging from mild flu-like symptoms to severe pneumonia, but extrarespiratory multisystemic involvement has also been reported.2 Li et al.3 recently described the neuroinvasive potential of COVID-19, but, to our knowledge, no case of acute dysimmune neuropathy has been described so far. Here, the authors report the case of an acute and severe peripheral nervous system disorder possibly related to COVID-19 infection.

Source: Neurology Neuroimmunology and Neuroinflammation - April 28, 2020 Category: Neurology Authors: Alberti, P., Beretta, S., Piatti, M., Karantzoulis, A., Piatti, M. L., Santoro, P., Vigano, M., Giovannelli, G., Pirro, F., Montisano, D. A., Appollonio, I., Ferrarese, C. Tags: Autoimmune diseases, Peripheral neuropathy, Guillain-Barre syndrome, COVID-19 Clinical/Scientific Notes Source Type: research